EquityFlow
›
Companies
› Medmain
Medmain
Healthtech
· Fukuoka, JP
Develops PidPort, an AI digital-pathology diagnosis solution.
Funding history
Date
Round
Amount
Jul 2022
Funding round
Medmain, maker of AI pathology tool PidPort, raised 300M JPY from PSP alongside a business alliance.
$2.2M
Investors
PSP
Similar companies in Healthtech
OurMind
TurnUp
Nanordica Medical
Uncovr
01Health
Rem3dy Health
Joyvié Health
Semble
Triomics
Musely
VITL
Ema Health
Explore funding flow on EquityFlow →